Correction to: Acta Pharmacologica Sinica https://doi.org/10.1038/aps.2017.161, published online 7 December 2017

The authors apologize that the images in Fig. 3B appeared incorrectly. We misassembled the tube formation images. The correct tube formation images in Fig. 3B are given. This correction does not affect the conclusions of the original article. We apologize again for any inconvenience caused.

Fig. 3: ASA VI enhanced migration and tube formation of HUVECs.
figure 1

A Transwell migration assay results of HUVECs with different treatments. HUVECs were treated with PBS (control), 50 ng/mL bFGF and 20, 40, and 80 μg/mL ASA VI in the lower chamber for 3 h incubation. The migration of HUVECs was enhanced after ASA VI treatment (scale bar: 50 μm). B In vitro tube formation results of HUVECs treated by ASA VI. The tube formation ability of HUVECs was improved after ASA VI treatment (scale bar: 200 μm). n = 3 independent experiments. *P < 0.05, **P < 0.01.

The correct Fig. 3 is shown below.